Global aortic valve market outlook and analysis by type, end user and region - Forecast till 2027. The global aortic valve market was valued at USD 6,454.91 million by 2027 and is likely to grow at an 11.1% CAGR between 2021- 2027, as per the recent report by Market Research Future (MRFR). Aortic valves are surgically transplanted into the heart to replace those that have become damaged as a result of heart valve conditions include atresia, regurgitation, and stenosis. The mortality and morbidity associated with aortic valve problems will be decreased by replacing the damaged valves with prosthetic heart valves. The two types of aortic valves that are utilised in both open surgery and minimally invasive surgery are biological and mechanical valves.

The expansion of the global aortic valve market is being fueled by a number of factors. Aortic regurgitation and aortic stenosis are two examples of such causes, according to the latest MRFR report, along with favourable government measures to raise awareness about valve replacement surgeries and the growing desire for minimally invasive procedures. Rising product approvals, the introduction of cutting-edge and creative items, and an ageing population are further drivers boosting market growth.

On the contrary, changing regulatory landscapes and product recalls are factors that may limit the global aortic valve market growth over the forecast period. 

Key players of aortic valve market

Eminent players profiled in the global aortic valve market report include TTK HealthCare (India), JenaValve (US), Colibri Heart Valve (US), Biotronik (Germany), CryoLife (US), Edwards Lifesciences Corporation (US), LivaNova PLC (UK), Abbott Laboratories (US), Medtronic(US), and Boston Scientific Corporation (US).  

Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global aortic valve market share based on end user, surgery, and type of valve. 

By valve type, the global aortic valve market is segmented into biological and mechanical. Of these, the mechanical valve segment will lead the market over the forecast period for its increasing use in replacement procedures. On the other hand, the biological valves segment will grow at a fast pace over the forecast period for growing awareness about the different benefits of using biological valves in the replacement procedure. 

By surgery type, the global aortic valve market is segmented into open surgery and minimally invasive surgery. The minimally invasive surgery segment is again segmented into trans-subclavian, transapical, transaortic implantation, and transfemoral. Of these, the minimally invasive surgery segment will dominate the market over the forecast period for faster recovery, less pain, and shorter hospital stay in comparison to open-heart surgery. 

By end users, the global aortic valve market is segmented into ambulatory surgery centers and hospitals. Among these, hospitals are likely to command the largest share in the aortic valve market over the forecast period. 

Regional Analysis

Based on the region, the global aortic valve market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market over the forecast period. Increasing cases of cardiovascular diseases and the presence of top market players in the region are adding market growth in the region. 

The global aortic valve market in Europe is predicted to have the second-largest share over the forecast period. Increasing prevalence of heart disease and growing support to control cardiovascular diseases from regulatory authorities are adding market growth in the region. 

The APAC region is predicted to experience rapid growth in the global aortic valve market during the projected period. The region's market is expanding due to shifting lifestyles in India, an ageing population, and rising healthcare costs.

Because of its restricted access to cutting-edge technologies and its underdeveloped healthcare system, the MEA is expected to have the smallest share of the global aortic valve market during the forecast period.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]

Website: https://www.marketresearchfuture.com